Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in Cervical Cancer
Cervical Cancer
Conditions: official terms
Uterine Cervical Neoplasms
Conditions: Keywords
Cervical cancer
Study Type
Study Phase
Phase 2
Study Design
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Name: paclitaxel Type: Drug
Name: Cisplatin 50mg/m2 Type: Drug
Overall Status
Purpose Primary endpoint

- To evaluate the 3-year disease free survival Second endpoints

- To evaluate the 3-year & 5-year overall survival To analyze the toxicity and the quality of life
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 70 Years
Minimum Age: 20 Years
Gender: Female
Criteria: Inclusion Criteria:

- cervical cancer stage Ia2-IIa

- histology; squamous, adeno, adenosquamous subtype

- age; 20∼70 years

- performance status; GOG 0∼2

- no medical illness

- hematologic, renal, hepatic function; normal

- grossly no residual disease

- histologically confirmed lymph nodes metastases

- no parametrial extension and negative resection margin

- number of retrieved lymph nodes; ≥ 20

Exclusion Criteria:

- patients with grade 2 peripheral neuropathy

- patients with uncontrolled infection
Seoul, Korea, Republic of
Status: Recruiting
Contact: Eunkyung Park - 8225125420 -
Start Date
January 2008
Completion Date
January 2015
Korean Gynecologic Oncology Group
Korean Gynecologic Oncology Group
Record processing date processed this data on July 28, 2015 page